Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosomes are membrane-bound organelles central to immune cell function but are not a single molecular target. In immune cells, lysosomes degrade proteins and pathogens through hydrolytic enzymes, and regulate antigen processing and presentation via MHC molecules, especially in dendritic cells and macrophages[1][4]. Lysosomal acid hydrolases, most notably cathepsins, are essential for antigen processing, cell signaling, cytokine secretion, and both cell survival and cell death pathways, including lysosomal-dependent cell death[1][3][6]. Lysosomes also integrate with immune signaling (such as Toll-like receptor signaling), support autophagy, and modulate immune cell migration and differentiation[2][4]. Their broad roles make them functionally crucial, but "lysosomal function in immune cells" is not a discrete therapeutic target, receptor, enzyme, or gene, but rather describes a vital process involving multiple molecular actors and pathways[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosome (function in immune cell).